Wellington Management Group LLP Lowers Stake in Trupanion, Inc. $TRUP

Wellington Management Group LLP lessened its stake in Trupanion, Inc. (NASDAQ:TRUP) by 31.5% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 50,487 shares of the financial services provider’s stock after selling 23,268 shares during the period. Wellington Management Group LLP owned about 0.12% of Trupanion worth $1,251,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new position in shares of Trupanion during the second quarter worth $134,774,000. Bank of America Corp DE acquired a new stake in shares of Trupanion in the second quarter valued at $14,262,000. Millennium Management LLC raised its holdings in shares of Trupanion by 185.8% in the 3rd quarter. Millennium Management LLC now owns 619,003 shares of the financial services provider’s stock valued at $26,790,000 after buying an additional 402,421 shares during the period. Renaissancere Holdings Ltd. purchased a new stake in shares of Trupanion in the 2nd quarter valued at $6,514,510. Finally, Goldman Sachs Group Inc. lifted its stake in Trupanion by 116.4% during the 4th quarter. Goldman Sachs Group Inc. now owns 477,014 shares of the financial services provider’s stock worth $17,826,000 after acquiring an additional 256,559 shares in the last quarter.

Insider Activity

In other news, CEO Margaret Tooth sold 978 shares of Trupanion stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $29.05, for a total value of $28,410.90. Following the completion of the transaction, the chief executive officer owned 175,401 shares in the company, valued at approximately $5,095,399.05. This trade represents a 0.55% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO John Gallagher sold 3,604 shares of the company’s stock in a transaction that occurred on Friday, August 28th. The stock was sold at an average price of $29.70, for a total transaction of $107,038.80. Following the sale, the chief operating officer owned 33,742 shares in the company, valued at $1,002,137.40. The trade was a 9.65% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 12,046 shares of company stock worth $356,210. 5.58% of the stock is currently owned by company insiders.

Trupanion Stock Down 0.4%

Shares of NASDAQ TRUP opened at $24.89 on Friday. The stock has a market cap of $1.09 billion, a P/E ratio of 46.96, a PEG ratio of 1.69 and a beta of 1.45. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.24. Trupanion, Inc. has a 12-month low of $21.16 and a 12-month high of $46.98. The business’s fifty day simple moving average is $27.41 and its 200-day simple moving average is $25.78.

Trupanion (NASDAQ:TRUP) last released its earnings results on Wednesday, August 5th. The financial services provider reported $0.16 EPS for the quarter, topping the consensus estimate of $0.11 by $0.05. Trupanion had a return on equity of 5.96% and a net margin of 1.53%.The firm had revenue of $392.93 million during the quarter, compared to analysts’ expectations of $389.72 million. During the same period in the previous year, the firm posted $0.22 EPS. Trupanion’s revenue for the quarter was up 11.1% on a year-over-year basis. As a group, equities analysts predict that Trupanion, Inc. will post 0.63 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on TRUP shares. Piper Sandler cut Trupanion from an “overweight” rating to a “neutral” rating and lowered their target price for the company from $45.00 to $32.00 in a report on Wednesday, August 26th. Stifel Nicolaus boosted their price target on shares of Trupanion from $28.00 to $29.00 and gave the stock a “hold” rating in a research note on Thursday, August 20th. Zacks Research cut shares of Trupanion from a “strong-buy” rating to a “hold” rating in a research report on Monday, August 24th. Atlantic Securities set a $42.00 price objective on shares of Trupanion in a research note on Wednesday, July 15th. Finally, Weiss Ratings cut shares of Trupanion from a “hold (c)” rating to a “hold (c-)” rating in a report on Thursday. One analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, Trupanion has an average rating of “Hold” and an average price target of $39.20.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.